Burke A, Davoren M, Arensman E, Harrington J
BMJ Open. 2024; 14(3):e077007.
PMID: 38521523
PMC: 10961541.
DOI: 10.1136/bmjopen-2023-077007.
Ihm S, Kim K, Lee K, Won J, Na J, Rha S
Korean Circ J. 2022; 52(1):1-33.
PMID: 34989192
PMC: 8738714.
DOI: 10.4070/kcj.2021.0226.
Carballo D, Rodondi N, Auer R, Carballo S, Nanchen D, Raber L
PLoS One. 2019; 14(2):e0211464.
PMID: 30789921
PMC: 6383891.
DOI: 10.1371/journal.pone.0211464.
Cezaretto A, Barros C, de Almeida-Pititto B, Siqueira-Catania A, Monfort-Pires M, Folchetti L
Arch Endocrinol Metab. 2017; 61(1):36-44.
PMID: 28273202
PMC: 10522123.
DOI: 10.1590/2359-3997000000185.
Kronish I, Moise N, McGinn T, Quan Y, Chaplin W, Gallagher B
J Gen Intern Med. 2016; 31(11):1294-1300.
PMID: 27255750
PMC: 5071278.
DOI: 10.1007/s11606-016-3757-4.
Theory of planned behavior and adherence in chronic illness: a meta-analysis.
Rich A, Brandes K, Mullan B, Hagger M
J Behav Med. 2015; 38(4):673-88.
PMID: 25994095
DOI: 10.1007/s10865-015-9644-3.
Systematic Review of Clinical Practice Guidelines for the Improvement of Medication Adherence.
Ruppar T, Dobbels F, Lewek P, Matyjaszczyk M, Siebens K, De Geest S
Int J Behav Med. 2015; 22(6):699-708.
PMID: 25805550
DOI: 10.1007/s12529-015-9479-x.
Single-component versus multicomponent dietary goals for the metabolic syndrome: a randomized trial.
Ma Y, Olendzki B, Wang J, Persuitte G, Li W, Fang H
Ann Intern Med. 2015; 162(4):248-57.
PMID: 25686165
PMC: 4456033.
DOI: 10.7326/M14-0611.
Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland.
Khan M, Shah S, Hameed T
J Pharm Bioallied Sci. 2014; 6(2):104-8.
PMID: 24741278
PMC: 3983739.
DOI: 10.4103/0975-7406.129175.
Relationships of clinic size, geographic region, and race/ethnicity to the frequency of missed/shortened dialysis treatments.
Obialo C, Zager P, Myers O, Hunt W
J Nephrol. 2014; 27(4):425-30.
PMID: 24446347
DOI: 10.1007/s40620-013-0035-y.
Impact of an integrated intervention program on atorvastatin adherence: a randomized controlled trial.
Goswami N, DeKoven M, Kuznik A, Mardekian J, Krukas M, Liu L
Int J Gen Med. 2013; 6:647-55.
PMID: 23935386
PMC: 3735272.
DOI: 10.2147/IJGM.S47518.
Enrollment and retention challenges in early-phase intervention development studies: the obesity-related behavioral intervention trials (ORBIT).
Boyington J, Czajkowski S
Prev Chronic Dis. 2013; 10.
PMID: 23469764
PMC: 3592786.
DOI: 10.5888/pcd10.130040.
A new characterization of adherence patterns to auto-adjusting positive airway pressure in severe obstructive sleep apnea syndrome: clinical and psychological determinants.
Sampaio R, Pereira M, Winck J
Sleep Breath. 2013; 17(4):1145-58.
PMID: 23386372
DOI: 10.1007/s11325-013-0814-7.
Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes.
Kassab Y, Hassan Y, Aziz N, Ismail O, AbdulRazzaq H
Int J Clin Pharm. 2013; 35(2):275-80.
PMID: 23283596
DOI: 10.1007/s11096-012-9735-y.
Present and future of secondary prevention after an acute coronary syndrome.
Keller P, Carballo S, Carballo D
EPMA J. 2012; 2(4):371-9.
PMID: 23199175
PMC: 3405406.
DOI: 10.1007/s13167-011-0129-3.
Beliefs about optimal age and screening frequency predict breast screening adherence in a prospective study of female relatives from the Ontario site of the Breast Cancer Family Registry.
Ritvo P, Edwards S, Glendon G, Mirea L, Knight J, Andrulis I
BMC Public Health. 2012; 12:518.
PMID: 22788119
PMC: 3432622.
DOI: 10.1186/1471-2458-12-518.
Actions to control hypertension among adults in Oklahoma.
Han J
Prev Chronic Dis. 2010; 8(1):A10.
PMID: 21159222
PMC: 3044021.
ASH position paper: Adherence and persistence with taking medication to control high blood pressure.
Hill M, Miller N, DeGeest S
J Clin Hypertens (Greenwich). 2010; 12(10):757-64.
PMID: 21029338
PMC: 8673243.
DOI: 10.1111/j.1751-7176.2010.00356.x.
Lifestyle and psychosocial risk factors predict non-adherence to medication.
Aggarwal B, Mosca L
Ann Behav Med. 2010; 40(2):228-33.
PMID: 20668975
PMC: 3102599.
DOI: 10.1007/s12160-010-9212-6.
Adherence and its measurement in phase 2/3 microbicide trials.
Tolley E, Harrison P, Goetghebeur E, Morrow K, Pool R, Taylor D
AIDS Behav. 2009; 14(5):1124-36.
PMID: 19924525
PMC: 2944966.
DOI: 10.1007/s10461-009-9635-x.
